Antioxidant activity of the monoamine oxidase B inhibitor lazabemide (Q43505805)

24 November 2017

title

Antioxidant activity of the monoamine oxidase B inhibitor lazabemide (English)

1 reference

24 November 2017

Mason RP

1

1 reference

24 November 2017

Olmstead EG

series ordinal

2

1 reference

24 November 2017

Jacob RF

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

24 November 2017

published in

Biochemical Pharmacology

1 reference

24 November 2017

volume

60

1 reference

24 November 2017

issue

5

1 reference

24 November 2017

page(s)

709-716

1 reference

Lipid peroxidation: its mechanism, measurement, and significance

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Brain membrane fluidity and lipid peroxidation in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Evidence of an oxidative challenge in the Alzheimer's brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Effect of Oxidative Stress on Membrane Structure: Small-Angle X-Ray Diffraction Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Diffusion of univalent ions across the lamellae of swollen phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

The separate profile structures of the functional calcium pump protein and the phospholipid bilayer within isolated sarcoplasmic reticulum membranes determined by X-ray and neutron diffraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

X-RAY DIFFRACTION PATTERN OF NERVE MYELIN: A METHOD FOR DETERMINING THE PHASES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Antioxidant and cytoprotective activities of the calcium channel blocker mibefradil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Effect of lipid physical state on the rate of peroxidation of liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Vitamin E protects nerve cells from amyloid beta protein toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Estrogen deficiency and risk of Alzheimer's disease in women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

The role of APP processing and trafficking pathways in the formation of amyloid beta-protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Free radicals and disruption of neuronal ion homeostasis in AD: a role for amyloid beta-peptide?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900374-9

10.1016/S0006-2952(00)00374-9

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference